Annual EBITDA:
$486.30M-$4.12B(-89.44%)Summary
- As of today, VRTX annual EBITDA is $486.30 million, with the most recent change of -$4.12 billion (-89.44%) on December 31, 2024.
- During the last 3 years, VRTX annual EBITDA has fallen by -$2.43 billion (-83.33%).
- VRTX annual EBITDA is now -89.44% below its all-time high of $4.61 billion, reached on December 31, 2023.
Performance
VRTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$1.33B+$104.60M(+8.52%)Summary
- As of today, VRTX quarterly EBITDA is $1.33 billion, with the most recent change of +$104.60 million (+8.52%) on September 30, 2025.
- Over the past year, VRTX quarterly EBITDA has increased by +$158.90 million (+13.55%).
- VRTX quarterly EBITDA is now at all-time high.
Performance
VRTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$4.73B+$158.90M(+3.48%)Summary
- As of today, VRTX TTM EBITDA is $4.73 billion, with the most recent change of +$158.90 million (+3.48%) on September 30, 2025.
- Over the past year, VRTX TTM EBITDA has increased by +$4.82 billion (+5466.06%).
- VRTX TTM EBITDA is now at all-time high.
Performance
VRTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VRTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -89.4% | +13.6% | +5466.1% |
| 3Y3 Years | -83.3% | +21.6% | +15.4% |
| 5Y5 Years | -68.8% | +88.1% | +70.8% |
VRTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -89.4% | at low | at high | +138.4% | at high | +2691.8% |
| 5Y | 5-Year | -89.4% | at low | at high | +138.4% | at high | +2691.8% |
| All-Time | All-Time | -89.4% | +169.0% | at high | +138.4% | at high | +811.9% |
VRTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.33B(+8.5%) | $4.73B(+3.5%) |
| Jun 2025 | - | $1.23B(+18.5%) | $4.57B(+3622.4%) |
| Mar 2025 | - | $1.04B(-8.6%) | -$129.70M(-636.0%) |
| Dec 2024 | $486.30M(-89.4%) | $1.13B(-3.4%) | $24.20M(+127.5%) |
| Sep 2024 | - | $1.17B(+133.8%) | -$88.10M(+51.7%) |
| Jun 2024 | - | -$3.47B(-391.8%) | -$182.40M(-104.2%) |
| Mar 2024 | - | $1.19B(+16.5%) | $4.35B(+10.0%) |
| Dec 2023 | $4.61B(+3.8%) | $1.02B(-5.4%) | $3.95B(-0.7%) |
| Sep 2023 | - | $1.08B(+1.9%) | $3.98B(-0.4%) |
| Jun 2023 | - | $1.06B(+33.4%) | $4.00B(+0.2%) |
| Mar 2023 | - | $793.90M(-24.2%) | $3.99B(-6.0%) |
| Dec 2022 | $4.44B(+52.0%) | $1.05B(-4.4%) | $4.24B(+3.5%) |
| Sep 2022 | - | $1.10B(+4.4%) | $4.10B(+0.1%) |
| Jun 2022 | - | $1.05B(+0.0%) | $4.09B(+33.9%) |
| Mar 2022 | - | $1.05B(+16.2%) | $3.06B(+4.1%) |
| Dec 2021 | $2.92B(-11.2%) | $902.99M(-17.4%) | $2.94B(+4.1%) |
| Sep 2021 | - | $1.09B(+8657.2%) | $2.82B(+15.8%) |
| Jun 2021 | - | $12.48M(-98.7%) | $2.44B(-23.2%) |
| Mar 2021 | - | $929.28M(+18.0%) | $3.17B(+6.4%) |
| Dec 2020 | $3.28B(+110.5%) | $787.40M(+11.2%) | $2.98B(+7.8%) |
| Sep 2020 | - | $707.93M(-5.3%) | $2.77B(+27.1%) |
| Jun 2020 | - | $747.56M(+1.1%) | $2.18B(+26.7%) |
| Mar 2020 | - | $739.72M(+29.3%) | $1.72B(+34.7%) |
| Dec 2019 | $1.56B(+109.4%) | $572.06M(+385.5%) | $1.28B(+46.1%) |
| Sep 2019 | - | $117.83M(-59.3%) | $873.73M(-10.7%) |
| Jun 2019 | - | $289.42M(-2.6%) | $978.84M(+10.8%) |
| Mar 2019 | - | $297.11M(+75.4%) | $883.10M(+20.8%) |
| Dec 2018 | $745.13M(+547.9%) | $169.37M(-24.0%) | $731.15M(+3.8%) |
| Sep 2018 | - | $222.95M(+15.1%) | $704.34M(+63.3%) |
| Jun 2018 | - | $193.67M(+33.4%) | $431.36M(+40.6%) |
| Mar 2018 | - | $145.17M(+1.8%) | $306.83M(-32.9%) |
| Dec 2017 | $115.01M(+52.4%) | $142.56M(+384.9%) | $457.35M(+23.6%) |
| Sep 2017 | - | -$50.04M(-172.4%) | $370.11M(-11.0%) |
| Jun 2017 | - | $69.15M(-76.6%) | $416.00M(+13.8%) |
| Mar 2017 | - | $295.69M(+434.6%) | $365.51M(+403.5%) |
| Dec 2016 | $75.46M(+118.3%) | $55.31M(+1432.9%) | $72.60M(+446.8%) |
| Sep 2016 | - | -$4.15M(-122.2%) | -$20.93M(+69.6%) |
| Jun 2016 | - | $18.66M(+573.1%) | -$68.82M(+71.6%) |
| Mar 2016 | - | $2.77M(+107.3%) | -$242.45M(+40.0%) |
| Dec 2015 | -$411.25M(+31.3%) | -$38.22M(+26.6%) | -$404.11M(+19.0%) |
| Sep 2015 | - | -$52.03M(+66.4%) | -$499.02M(+6.1%) |
| Jun 2015 | - | -$154.97M(+2.5%) | -$531.39M(+2.2%) |
| Mar 2015 | - | -$158.89M(-19.4%) | -$543.35M(+6.1%) |
| Dec 2014 | -$598.75M(-7.9%) | -$133.13M(-57.7%) | -$578.87M(-36.5%) |
| Sep 2014 | - | -$84.40M(+49.4%) | -$424.02M(+6.2%) |
| Jun 2014 | - | -$166.93M(+14.1%) | -$452.15M(-36.7%) |
| Mar 2014 | - | -$194.41M(-994.8%) | -$330.82M(-119.0%) |
| Dec 2013 | -$554.75M(-750.9%) | $21.73M(+119.3%) | -$151.06M(+36.4%) |
| Sep 2013 | - | -$112.53M(-146.8%) | -$237.70M(-103.2%) |
| Jun 2013 | - | -$45.60M(-211.1%) | -$116.95M(-60.5%) |
| Mar 2013 | - | -$14.66M(+77.4%) | -$72.86M(-272.0%) |
| Dec 2012 | $85.23M(-36.0%) | -$64.91M(-889.8%) | $42.37M(-87.6%) |
| Sep 2012 | - | $8.22M(+643.9%) | $341.89M(-48.4%) |
| Jun 2012 | - | -$1.51M(-101.5%) | $662.51M(+30.5%) |
| Mar 2012 | - | $100.57M(-57.1%) | $507.58M(+97.7%) |
| Dec 2011 | $133.17M(+118.9%) | $234.62M(-28.7%) | $256.74M(+285.3%) |
| Sep 2011 | - | $328.84M(+310.2%) | -$138.57M(+79.0%) |
| Jun 2011 | - | -$156.44M(-4.1%) | -$659.37M(+0.5%) |
| Mar 2011 | - | -$150.28M(+6.5%) | -$662.48M(+0.2%) |
| Dec 2010 | -$704.89M(-17.7%) | -$160.69M(+16.3%) | -$664.12M(-5.0%) |
| Sep 2010 | - | -$191.96M(-20.3%) | -$632.61M(-8.8%) |
| Jun 2010 | - | -$159.55M(-5.0%) | -$581.29M(-2.0%) |
| Mar 2010 | - | -$151.92M(-17.6%) | -$570.06M(-1.3%) |
| Dec 2009 | -$598.88M(-40.5%) | -$129.18M(+8.2%) | -$562.67M(+0.4%) |
| Sep 2009 | - | -$140.64M(+5.2%) | -$565.14M(-3.5%) |
| Jun 2009 | - | -$148.31M(-2.6%) | -$546.29M(-13.8%) |
| Mar 2009 | - | -$144.53M(-9.8%) | -$480.11M(-12.7%) |
| Dec 2008 | -$426.19M(-10.6%) | -$131.65M(-8.1%) | -$426.19M(-12.6%) |
| Sep 2008 | - | -$121.79M(-48.3%) | -$378.56M(-4.3%) |
| Jun 2008 | - | -$82.14M(+9.3%) | -$362.85M(+9.0%) |
| Mar 2008 | - | -$90.61M(-7.8%) | -$398.57M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | -$385.21M(-93.1%) | -$84.02M(+20.8%) | -$385.21M(-17.4%) |
| Sep 2007 | - | -$106.08M(+10.0%) | -$328.23M(-18.5%) |
| Jun 2007 | - | -$117.86M(-52.6%) | -$276.93M(-19.9%) |
| Mar 2007 | - | -$77.25M(-185.8%) | -$231.03M(-15.8%) |
| Dec 2006 | -$199.52M(-74.3%) | -$27.03M(+50.7%) | -$199.52M(-7.5%) |
| Sep 2006 | - | -$54.78M(+23.9%) | -$185.59M(-12.7%) |
| Jun 2006 | - | -$71.97M(-57.3%) | -$164.70M(-30.2%) |
| Mar 2006 | - | -$45.74M(-249.0%) | -$126.54M(-10.6%) |
| Dec 2005 | -$114.45M(-6.4%) | -$13.11M(+61.3%) | -$114.45M(+14.4%) |
| Sep 2005 | - | -$33.89M(-0.2%) | -$133.75M(-4.3%) |
| Jun 2005 | - | -$33.81M(-0.5%) | -$128.25M(-0.5%) |
| Mar 2005 | - | -$33.65M(-3.8%) | -$127.55M(-5.0%) |
| Dec 2004 | -$107.59M(+27.9%) | -$32.41M(-14.2%) | -$121.51M(-3.7%) |
| Sep 2004 | - | -$28.38M(+14.3%) | -$117.13M(+9.3%) |
| Jun 2004 | - | -$33.11M(-20.0%) | -$129.16M(+3.2%) |
| Mar 2004 | - | -$27.61M(+1.5%) | -$133.46M(+10.2%) |
| Dec 2003 | -$149.26M(-21.3%) | -$28.04M(+30.6%) | -$148.63M(-1.1%) |
| Sep 2003 | - | -$40.40M(-8.0%) | -$146.96M(-8.2%) |
| Jun 2003 | - | -$37.41M(+12.5%) | -$135.84M(-16.9%) |
| Mar 2003 | - | -$42.78M(-62.2%) | -$116.17M(-23.4%) |
| Dec 2002 | -$123.05M(-26.7%) | -$26.37M(+9.9%) | -$94.17M(-25.2%) |
| Sep 2002 | - | -$29.28M(-65.0%) | -$75.24M(-26.0%) |
| Jun 2002 | - | -$17.75M(+14.6%) | -$59.71M(-6.0%) |
| Mar 2002 | - | -$20.78M(-179.4%) | -$56.34M(-16.3%) |
| Dec 2001 | -$97.14M(-294.0%) | -$7.44M(+45.9%) | -$48.44M(+8.0%) |
| Sep 2001 | - | -$13.74M(+4.4%) | -$52.67M(-1.7%) |
| Jun 2001 | - | -$14.38M(-11.6%) | -$51.80M(-100.5%) |
| Mar 2001 | - | -$12.88M(-10.4%) | -$25.83M(+12.7%) |
| Dec 2000 | -$24.65M(+44.4%) | -$11.67M(+9.4%) | -$29.59M(-461.3%) |
| Sep 2000 | - | -$12.87M(-211.1%) | $8.19M(+27.6%) |
| Jun 2000 | - | $11.59M(+169.6%) | $6.42M(+137.9%) |
| Mar 2000 | - | -$16.64M(-163.7%) | -$16.94M(+13.0%) |
| Dec 1999 | -$44.30M(-2.5%) | $26.11M(+278.3%) | -$19.48M(+67.7%) |
| Sep 1999 | - | -$14.64M(-24.4%) | -$60.24M(-19.7%) |
| Jun 1999 | - | -$11.77M(+38.6%) | -$50.34M(+1.4%) |
| Mar 1999 | - | -$19.17M(-30.8%) | -$51.07M(-18.1%) |
| Dec 1998 | -$43.20M(-176.9%) | -$14.65M(-209.2%) | -$43.23M(-26.9%) |
| Sep 1998 | - | -$4.74M(+62.1%) | -$34.07M(-0.1%) |
| Jun 1998 | - | -$12.51M(-10.4%) | -$34.03M(-55.2%) |
| Mar 1998 | - | -$11.33M(-106.0%) | -$21.93M(-42.4%) |
| Dec 1997 | -$15.60M(+57.0%) | -$5.50M(-17.0%) | -$15.40M(+36.9%) |
| Sep 1997 | - | -$4.70M(-1075.0%) | -$24.40M(+7.2%) |
| Jun 1997 | - | -$400.00K(+91.7%) | -$26.30M(+21.0%) |
| Mar 1997 | - | -$4.80M(+66.9%) | -$33.30M(+8.3%) |
| Dec 1996 | -$36.30M(-59.2%) | -$14.50M(-119.7%) | -$36.30M(-57.1%) |
| Sep 1996 | - | -$6.60M(+10.8%) | -$23.10M(+1.7%) |
| Jun 1996 | - | -$7.40M(+5.1%) | -$23.50M(+8.6%) |
| Mar 1996 | - | -$7.80M(-500.0%) | -$25.70M(-12.7%) |
| Dec 1995 | -$22.80M(-32.6%) | -$1.30M(+81.4%) | -$22.80M(+21.1%) |
| Sep 1995 | - | -$7.00M(+27.1%) | -$28.90M(-16.1%) |
| Jun 1995 | - | -$9.60M(-95.9%) | -$24.90M(-25.8%) |
| Mar 1995 | - | -$4.90M(+33.8%) | -$19.80M(-15.1%) |
| Dec 1994 | -$17.20M(-437.3%) | -$7.40M(-146.7%) | -$17.20M(>-9900.0%) |
| Sep 1994 | - | -$3.00M(+33.3%) | -$100.00K(-111.1%) |
| Jun 1994 | - | -$4.50M(-95.7%) | $900.00K(-83.6%) |
| Mar 1994 | - | -$2.30M(-123.7%) | $5.50M(+7.8%) |
| Dec 1993 | $5.10M(+170.8%) | $9.70M(+585.0%) | $5.10M(+175.0%) |
| Sep 1993 | - | -$2.00M(-2100.0%) | -$6.80M(-1.5%) |
| Jun 1993 | - | $100.00K(+103.7%) | -$6.70M(+19.3%) |
| Mar 1993 | - | -$2.70M(-22.7%) | -$8.30M(-16.9%) |
| Dec 1992 | -$7.20M(-89.5%) | -$2.20M(-15.8%) | -$7.10M(-16.4%) |
| Sep 1992 | - | -$1.90M(-26.7%) | -$6.10M(-17.3%) |
| Jun 1992 | - | -$1.50M(0.0%) | -$5.20M(-15.6%) |
| Mar 1992 | - | -$1.50M(-25.0%) | -$4.50M(-104.5%) |
| Dec 1991 | -$3.80M(+7.3%) | -$1.20M(-20.0%) | -$2.20M(+67.6%) |
| Sep 1991 | - | -$1.00M(-25.0%) | -$6.80M(-30.8%) |
| Jun 1991 | - | -$800.00K(-200.0%) | -$5.20M(-36.8%) |
| Mar 1991 | - | $800.00K(+113.8%) | -$3.80M(+7.3%) |
| Dec 1990 | -$4.10M | -$5.80M(-1066.7%) | -$4.10M(-341.2%) |
| Sep 1990 | - | $600.00K(0.0%) | $1.70M(+54.5%) |
| Jun 1990 | - | $600.00K(+20.0%) | $1.10M(+120.0%) |
| Mar 1990 | - | $500.00K | $500.00K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual EBITDA?
- What is the all-time high annual EBITDA for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual EBITDA year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly EBITDA year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM EBITDA?
- What is the all-time high TTM EBITDA for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM EBITDA year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual EBITDA?
The current annual EBITDA of VRTX is $486.30M
What is the all-time high annual EBITDA for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual EBITDA is $4.61B
What is Vertex Pharmaceuticals Incorporated annual EBITDA year-on-year change?
Over the past year, VRTX annual EBITDA has changed by -$4.12B (-89.44%)
What is Vertex Pharmaceuticals Incorporated quarterly EBITDA?
The current quarterly EBITDA of VRTX is $1.33B
What is the all-time high quarterly EBITDA for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly EBITDA is $1.33B
What is Vertex Pharmaceuticals Incorporated quarterly EBITDA year-on-year change?
Over the past year, VRTX quarterly EBITDA has changed by +$158.90M (+13.55%)
What is Vertex Pharmaceuticals Incorporated TTM EBITDA?
The current TTM EBITDA of VRTX is $4.73B
What is the all-time high TTM EBITDA for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM EBITDA is $4.73B
What is Vertex Pharmaceuticals Incorporated TTM EBITDA year-on-year change?
Over the past year, VRTX TTM EBITDA has changed by +$4.82B (+5466.06%)